BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24474236)

  • 21. Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma.
    Halec G; Holzinger D; Schmitt M; Flechtenmacher C; Dyckhoff G; Lloveras B; Höfler D; Bosch FX; Pawlita M
    Br J Cancer; 2013 Jul; 109(1):172-83. PubMed ID: 23778529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into human papillomavirus-associated head and neck squamous cell carcinoma.
    Boscolo-Rizzo P; Del Mistro A; Bussu F; Lupato V; Baboci L; Almadori G; DA Mosto MC; Paludetti G
    Acta Otorhinolaryngol Ital; 2013 Apr; 33(2):77-87. PubMed ID: 23853396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Papillomavirus 16 DNA Methylation Patterns and Investigation of Integration Status in Head and Neck Cancer Cases.
    Zygouras I; Leventakou D; Pouliakis A; Panagiotou S; Tsakogiannis D; Konstantopoulos G; Logotheti E; Samaras M; Kyriakopoulou Z; Beloukas A; Pateras IS; Delides A; Psyrri A; Panayiotides IG; Yiangou M; Kottaridi C
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
    Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
    Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer.
    Zhang Y; Sturgis EM; Sun Y; Sun C; Wei Q; Huang Z; Li G
    Eur J Cancer; 2015 Jul; 51(11):1415-23. PubMed ID: 25981582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades.
    Das LC; Karrison TG; Witt ME; Muller C; Stenson K; Blair EA; Cohen EEW; Seiwert TY; Haraf DJ; Vokes EE
    Ann Oncol; 2015 Jan; 26(1):198-205. PubMed ID: 25361984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.
    Brenner N; Mentzer AJ; Hill M; Almond R; Allen N; Pawlita M; Waterboer T
    EBioMedicine; 2020 Dec; 62():103123. PubMed ID: 33248371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dual role of autophagy in HPV-positive head and neck squamous cell carcinoma: a systematic review.
    Kandathil SA; Akhondi A; Kadletz-Wanke L; Heiduschka G; Engedal N; Brkic FF
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):56. PubMed ID: 38291202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus-active head and neck cancer and ethnic health disparities.
    Weinberger PM; Merkley MA; Khichi SS; Lee JR; Psyrri A; Jackson LL; Dynan WS
    Laryngoscope; 2010 Aug; 120(8):1531-7. PubMed ID: 20564751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review: Head and neck squamous cell carcinoma in sub-Saharan Africa.
    Faggons CE; Mabedi C; Shores CG; Gopal S
    Malawi Med J; 2015 Sep; 27(3):79-87. PubMed ID: 26715951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.
    Berglund A; Muenyi C; Siegel EM; Ajidahun A; Eschrich SA; Wong D; Hendrick LE; Putney RM; Kim S; Hayes DN; Shibata D
    Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):858-869. PubMed ID: 35064062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combined HPV16-E2/E6/E7 T cell response in oropharyngeal cancer predicts superior survival.
    Santegoets SJ; Stolk A; Welters MJP; van der Burg SH
    Cell Rep Med; 2023 Nov; 4(11):101262. PubMed ID: 37924817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran.
    Karimi A; Mohebbi E; Mckay-Chopin S; Rashidian H; Hadji M; Peyghambari V; Marzban M; Naghibzadeh-Tahami A; Gholipour M; Kamangar F; Tommasino M; Gheit T; Zendehdel K
    Microbiol Spectr; 2022 Aug; 10(4):e0011722. PubMed ID: 35708339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer.
    D'Souza G; Clemens G; Troy T; Castillo RG; Struijk L; Waterboer T; Bender N; Pierorazio PM; Best SR; Strickler H; Wiley DJ; Haddad RI; Posner M; Fakhry C
    Cancer Prev Res (Phila); 2019 Oct; 12(10):689-700. PubMed ID: 31420362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma.
    Azzimonti B; Raimondo L; Squarzanti DF; Rosso T; Zanetta P; Aluffi Valletti P; Chiusa L; Masini L; Pecorari G; Airoldi M; Krengli M; Giovarelli M; Valente G
    Ann Med; 2021 Dec; 53(1):541-550. PubMed ID: 33769181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with integrated HPV16 in head and neck cancer show poor survival.
    Nulton TJ; Kim NK; DiNardo LJ; Morgan IM; Windle B
    Oral Oncol; 2018 May; 80():52-55. PubMed ID: 29706188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No role for human papillomavirus in esophageal squamous cell carcinoma in China.
    Koshiol J; Wei WQ; Kreimer AR; Chen W; Gravitt P; Ren JS; Abnet CC; Wang JB; Kamangar F; Lin DM; von Knebel-Doeberitz M; Zhang Y; Viscidi R; Wang GQ; Gillison ML; Roth MJ; Dong ZW; Kim E; Taylor PR; Qiao YL; Dawsey SM
    Int J Cancer; 2010 Jul; 127(1):93-100. PubMed ID: 19918949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania.
    Ursu RG; Danciu M; Spiridon IA; Ridder R; Rehm S; Maffini F; McKay-Chopin S; Carreira C; Lucas E; Costan VV; Popescu E; Cobzeanu B; Ghetu N; Iancu LS; Tommasino M; Pawlita M; Holzinger D; Gheit T
    PLoS One; 2018; 13(6):e0199663. PubMed ID: 29940024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
    D'Souza G; Tewari SR; Troy T; Waterboer T; Struijk L; Castillo R; Wright H; Shen M; Miles B; Johansson M; Robbins HA; Fakhry C
    Cancer; 2023 Aug; 129(15):2373-2384. PubMed ID: 37032449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A TGF-β1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer.
    Tao Y; Sturgis EM; Huang Z; Sun Y; Dahlstrom KR; Wei Q; Li G
    Int J Cancer; 2018 Sep; 143(6):1327-1334. PubMed ID: 29663347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.